These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6447614)

  • 21. In vitro trypanocidal activity of dibutyltin dichloride and its fatty acid derivatives.
    Shuaibu MN; Kanbara H; Yanagi T; Ichinose A; Ameh DA; Bonire JJ; Nok AJ
    Parasitol Res; 2003 Sep; 91(1):5-11. PubMed ID: 12851812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin.
    Ishiyama A; Otoguro K; Iwatsuki M; Namatame M; Nishihara A; Nonaka K; Kinoshita Y; Takahashi Y; Masuma R; Shiomi K; Yamada H; Omura S
    J Antibiot (Tokyo); 2009 Jun; 62(6):303-8. PubMed ID: 19407848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate.
    Witola WH; Inoue N; Ohashi K; Onuma M
    Exp Parasitol; 2004; 107(1-2):47-57. PubMed ID: 15208037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense.
    Merschjohann K; Sporer F; Steverding D; Wink M
    Planta Med; 2001 Oct; 67(7):623-7. PubMed ID: 11582539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity.
    Dardonville C; Barrett MP; Brun R; Kaiser M; Tanious F; Wilson WD
    J Med Chem; 2006 Jun; 49(12):3748-52. PubMed ID: 16759117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of extracts and naphthoquinones from Kigelia pinnata against Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
    Moideen SV; Houghton PJ; Rock P; Croft SL; Aboagye-Nyame F
    Planta Med; 1999 Aug; 65(6):536-40. PubMed ID: 10483374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma brucei: suramin and other trypanocidal compounds' effects on sn-glycerol-3-phosphate oxidase.
    Fairlamb AH; Bowman IB
    Exp Parasitol; 1977 Dec; 43(2):353-61. PubMed ID: 598447
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence for a non-LDL-mediated entry route for the trypanocidal drug suramin in Trypanosoma brucei.
    Pal A; Hall BS; Field MC
    Mol Biochem Parasitol; 2002 Jul; 122(2):217-21. PubMed ID: 12106876
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening compounds for sleeping sickness therapy without relapse.
    Ormerod WE; Raseroka BH
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):543-7. PubMed ID: 2461813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, DNA binding and antitrypanosomal activity of benzimidazole analogues of DAPI.
    Farahat AA; Bennett-Vaughn C; Mineva EM; Kumar A; Wenzler T; Brun R; Liu Y; Wilson WD; Boykin DW
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5907-5910. PubMed ID: 27843114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent studies on inhibitors of macromolecular synthesis and function in trypanosomes.
    Meshnick SR
    Pharmacol Ther; 1984; 25(2):239-54. PubMed ID: 6209734
    [No Abstract]   [Full Text] [Related]  

  • 32. Trypanocidal resistance in Trypanosoma evansi in vitro: effects of verapamil, cyproheptidine, desipramine and chlorpromazine alone and in combination with trypanocides.
    Anene BM; Ross CA; Anika SM; Chukwu CC
    Vet Parasitol; 1996 Mar; 62(1-2):43-50. PubMed ID: 8638392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of trypanocidal drugs on protein biosynthesis in vitro and in vivo by Trypanosoma cruzi.
    Gonzalez NS; Cazzulo JJ
    Biochem Pharmacol; 1989 Sep; 38(17):2873-7. PubMed ID: 2673249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.
    Mackey ZB; Baca AM; Mallari JP; Apsel B; Shelat A; Hansell EJ; Chiang PK; Wolff B; Guy KR; Williams J; McKerrow JH
    Chem Biol Drug Des; 2006 May; 67(5):355-63. PubMed ID: 16784460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
    Nwodo NJ; Brun R; Osadebe PO
    J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisguanidine, bis(2-aminoimidazoline), and polyamine derivatives as potent and selective chemotherapeutic agents against Trypanosoma brucei rhodesiense. Synthesis and in vitro evaluation.
    Dardonville C; Brun R
    J Med Chem; 2004 Apr; 47(9):2296-307. PubMed ID: 15084128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.
    Venkatraj M; Ariën KK; Heeres J; Joossens J; Dirié B; Lyssens S; Michiels J; Cos P; Lewi PJ; Vanham G; Maes L; Van der Veken P; Augustyns K
    Bioorg Med Chem; 2014 Oct; 22(19):5241-8. PubMed ID: 25199582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Different effects of nifurtimox and benznidazole on the biosynthesis of DNA, RNA and proteins in Trypanosoma cruzi].
    Goijman SG; Frasch AC; Stoppani AO
    Medicina (B Aires); 1984; 44(3):261-70. PubMed ID: 6085847
    [No Abstract]   [Full Text] [Related]  

  • 39. Manadoperoxides, a new class of potent antitrypanosomal agents of marine origin.
    Chianese G; Fattorusso E; Scala F; Teta R; Calcinai B; Bavestrello G; Dien HA; Kaiser M; Tasdemir D; Taglialatela-Scafati O
    Org Biomol Chem; 2012 Sep; 10(35):7197-207. PubMed ID: 22859016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.